Abstract:
AIM To investigate the effects and pharmacological mechanisms of vinpocetine in patients with severe acute pancreatitis (SAP).
METHODS Forty SD rats were randomly divided into 4 groups: control group, sham group, SAP model group and SAP model+vinpocetine group, with 10 rats in each group. Echocardiography was used to evaluate rat cardiac functions and H&E staining was used to detect myocardial tissue morphological changes. Serum levels of inflammatory cytokines TNF-α, IL-1β, IL-6 and HMGB1 were determined by ELISA, the levels of SIRT1 and HMGB1 in rats pancreatic tissues were determined by Western blot and the direct interaction of SIRT1 and HMGB1 was determined by co-IP.
RESULTS Compared with those in control group, the heart rate and left ventricular diastolic blood pressure in SAP model group were significantly increased (P<0.05), left ventricular ejection fraction, left ventricular fractional shortening and left ventricular systolic blood pressure were significantly decreased (P<0.05). The levels of serum TNF-α, IL-1β, IL-6, creatine kinase isoenzyme (CK-MB) and HMGB1 (high mobility group box-1) were significantly increased (P<0.05). The level of HMGB1 in rat pancreatic tissues was significantly increased and the level of SIRT1 (silent information regulator 1) was significantly decreased (P<0.05). Compared with SAP model group, SAP model+vinpocetine group significantly reversed the above indexes (P<0.05). There was no significant difference between sham group and control group . Myc-SIRT1 and Flag-HMGB1-A were co-transfected and expressed in HEK 293T cells, and proteins containing Myc tags could be detected in the proteins pulled down by anti-Flag antibodies. Compared with those in control group, the expression level of HMGB1 in LPS group of HEK 293T cells was significantly increased, and the expression level of SIRT1 was significantly decreased (P<0.05).
CONCLUSION Vinpocetine alleviates myocardial injury and protects cardiac functions in SAP rat model by up-regulating SIRT1 to deacetylate HMGB1 and down-regulate HMGB1.